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Fluid therapy is still the mainstay of acute care in patients with shock or cardiovascular compromise. However, our understanding
of the critically ill pathophysiology has evolved significantly in recent years. The revelation of the glycocalyx layer and subsequent
research has redefined the basics of fluids behavior in the circulation. Using less invasive hemodynamicmonitoring tools enables us
to assess the cardiovascular function in a dynamic perspective.This allows pinpointing even distinct changes induced by treatment,
by postural changes, or by interorgan interactions in real time and enables individualized patient management. Regarding fluids as
drugs of any other kind led to the need for precise indication, way of administration, and also assessment of side effects. We possess
now the evidence that patient centered outcomes may be altered when incorrect time, dose, or type of fluids are administered. In
this review, three major features of fluid therapy are discussed: the prediction of fluid responsiveness, potential harms induced by
overzealous fluid administration, and finally the problem of protocol-led treatments and their timing.
1. Introduction
In patients with acute circulatory failure, the primary goal of
volume expansion is to increase cardiac output, hence oxygen
delivery to the tissues. However, this effect is inconstant [1]:
in many instances, fluid administration does not result in
any hemodynamic benefits. In such cases, fluids may exert
deleterious effects. In this regard, it is now well demon-
strated that excessive fluid administration is associated with
increased mortality, especially during acute respiratory dis-
tress syndrome (ARDS) [2] and in sepsis or septic shock
[3, 4]. Whether this association between increased mortality
and fluid accumulation is only an epiphenomenon based on
illness severity or whether fluids exert harmful effect per
se has to be further elucidated. However, in reality both
features may contribute in part to what makes adequate fluid
administration even more important. This is in contrast with
the rather benevolent and uncoordinated use of fluids by
clinicians worldwide as demonstrated in the recent FENICE
trial [5]. In this review, we will focus on three major features
of fluid therapy, which can be regarded as a double-edged
sword: the prediction of fluid responsiveness, potential harms
induced by overzealous fluid administration, and finally the
problem of protocol-led treatments and their timing.
2. Predicting Fluid Responsiveness
The risks associated with improper fluid administration led
to development of several strategies to assess “fluid respon-
siveness” before performing volume expansion. Although
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conventional parameters of preload have been used for
decades for testing fluid responsiveness, their unreliability
has been demonstrated by several studies [6]. Therefore,
“dynamic” indices have been introduced in order to replace
these unreliable “static” markers of preload. These dynamic
indices are based on the changes in cardiac output or
stroke volume resulting from changes in preload, induced
by mechanical ventilation, by postural maneuvers, or by the
infusion of small amounts of fluids [7]. In this chapter, we will
describe the advantages and drawbacks of these “dynamic”
indices of fluid responsiveness and the clinical setting where
they may be applicable.
2.1. Static Indices of Cardiac Preload. It is today clearly
established that static markers of cardiac preload, such as
the central venous pressure or pulmonary artery occlusion
pressure, are unable to predict what effect will fluid admin-
istration have on cardiac output [6, 8]. The main explanation
comes from basic physiology. Indeed, the slope of the cardiac
function curve depends on the cardiac systolic function
(Figure 1). Since this slope is unknown in a given patient, an
absolute value of any “static” measure of preload could corre-
spond to preload dependence and to preload independence.
Another explanation for the unreliability of static markers
of preload comes from the errors that can occur in their
measurements. For instance, the measurement of central
venous pressure requires a precise positioning of the pressure
transducer with respect to the right atrium. It must also be
carefully measured at end-expiration and should take into
account the transmission of intrathoracic pressure to the right
atrium. Similarly, the pulmonary artery occlusion pressure
suffers from many possible errors in its measurement and
interpretation [9]. To address shortcomings of these static
indices, alternative methods have been developed to predict
preload responsiveness.They fit in an overall concept of func-
tional hemodynamic monitoring. They consist in observing
some changes in cardiac preload, induced by mechanical
ventilation, leg raising, or fluid challenges and in observing
the resultant change of cardiac output or stroke volume [10].
2.2. Variations of Stroke Volume Induced by
Mechanical Ventilation
2.2.1. Physiological Background. During mechanical ven-
tilation, insufflation increases the intrathoracic pressure,
increases the right atrial pressure, and hence decreases the
pressure gradient of venous return. If the right ventricle
is preload-dependent, this will inevitably reduce the right
ventricular outflow. Increase in right ventricular afterload
induced by increased lung volume contributes to this reduc-
tion of right ventricular outflow during inspiration. As
certain time is needed for the transit of blood through the pul-
monary vasculature, this will reduce left ventricular preload.
During conventional ventilation, this should occur at expira-
tion. If the left ventricle is preload-dependent, the left ventric-
ular stroke volume transiently decreases at expiration. Hence,
a cyclic variation of stroke volume under mechanical ventila-
tion indicates preload-dependence of both ventricles [11].
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Figure 1: Cardiac function curve. There is a family of cardiac
function curves depending on the ventricular contractility. If the
ventricles are functioning on the steep part of cardiac function
curve, changes in cardiac preload induced by mechanical ventila-
tion, end-expiratory occlusion (EEO), passive leg raising (PLR), or
“mini fluid challenge” result in significant changes in stroke volume.
This is not the case if the ventricles are functioning on the steep part
of cardiac function curve.
2.2.2. How to Assess the Respiratory Variations of Stroke
Volume? Several surrogates or estimates of stroke volume
have been used in order to quantify these respiratory varia-
tions. The first one was the systemic arterial pulse pressure
[12], which is proportional to stroke volume. A number
of studies have actually demonstrated that pulse pressure
variation (PPV) is a reliable indicator of fluid responsiveness,
provided that the conditions of its validity are fulfilled. The
large number of these studies and a positive meta-analysis
[13] contributed to establishment of a large and solid base
of evidence for this indicator. Overall, the cut-off above
which PPV is considered as significantly associated with fluid
responsiveness is around 13%. Of course, as for many tests,
this is not a strict cut-off.The farther from 13% the PPV value
is, the higher is its diagnostic power.
Alongside PPV, other estimates of stroke volume have
been used to predict preload responsiveness through their
respiratory variations: stroke volume estimated by pulse
contour analysis, blood flow of the left ventricular out-
flow tract measured by echocardiography, aortic blood flow
assessed by esophageal Doppler, and the amplitude of the
plethysmography signal recorded by pulse oximetry [1].
2.2.3. Conditions of Validity, Advantages, and Limitations.
The respiratory variation of stroke volume as a marker of
preload responsiveness is not valid under some conditions.
First, in case of spontaneous breathing activity, stroke vol-
ume variations relate more to the respiratory irregularity
compared to preload dependence [14]. Second, in case of
cardiac arrhythmias, the variation of stroke volume within
the respiratory cycles is obviously more related to arrhythmia
itself than to heart-lung interactions. The third important
limitation refers to ARDS [15]. In such cases, low tidal
volume and/or low lung compliance [16], which reduces
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the transmission of changes in alveolar pressure to the
intrathoracic structures, both can diminish the amplitude
of the ventilation-induced changes of intravascular pressure.
This may result in false negative predictions of fluid respon-
siveness by PPV. Open chest surgery due to the low ratio
of heart rate over respiratory rate [17] (corresponding in
fact to respiratory rates at 40 breaths/minute or more) and
intra-abdominal hypertension [18] are other circumstances
in which PPV is unreliable to predict fluid responsiveness
[10]. Overall, the limitations to the use of PPV aremuchmore
frequently encountered in the intensive care unit than in the
operating theatre [19, 20].
2.2.4. Respiratory Variation of Venae Cavae. Mechanical
ventilation could induce some changes in the diameter of
venae cavae. Due to their high compliance, the changes are
more likely to be observed in case of hypovolemia than in
case of normo- or hypervolemia. The respiratory variation of
the diameter of the inferior vena cava at the point where it
enters the thorax was demonstrated to reliably predict fluid
responsiveness [21]. This was also the case for the collapsi-
bility of the superior vena cava [22]. The most important
limitation of these methods is that they have only limited
predictive value in case of spontaneous breathing activity
[23] mainly because of inhomogeneous respiratory efforts.
As for PPV, low lung compliance and mechanical ventilation
with a low tidal volume should theoretically minimize the
effect of ventilation on the vena cava diameter and may thus
invalidate the method. By contrast, these methods can be
used in case of cardiac arrhythmias.The respiratory variation
of the inferior vena cava is simple tomeasure by transthoracic
echocardiography, which represents an important advantage.
This could be particularly useful at the early phase of care,
when arterial cannulation is yet to be done. The collapsibility
of the superior vena cava is much more difficult to measure
and requires transesophageal echocardiography. In a patient
equipped with an arterial catheter, it is easier to use PPV than
the superior vena cava collapsibility.
2.3. The End-Expiratory Occlusion (EEO) Test
2.3.1. Hemodynamic Effects. As stated above, during the
mechanical ventilatory cycle cardiac preload is reduced
in inspiration. Stopping mechanical ventilation at end-
expiration for a few seconds interrupts this cyclic decrease,
meaning that end-expiratory occlusion (EEO) induces a
transient increase in cardiac preload. This increase allows
testing preload dependence. If the right ventricle is preload-
dependent, the EEOwill lead to an increased right ventricular
output. If the duration of EEO is long enough for the
transmission of this increased output toward the left cardiac
cavities through the pulmonary circulation, left ventricu-
lar preload will increase. If the left ventricle is preload-
dependent, EEO will eventually provoke an increase in
cardiac output (Figure 1). Some studies consistently showed
that if cardiac output increases by more than 5% during a 15-
second EEO test, volume responsiveness could be predicted
with a good reliability [16, 24].
2.3.2. Advantages and Limitations. Beyond its simplicity, an
advantage of the EEO test is that it can be used in case of
cardiac arrhythmias since it exerts its effects on a period of
time (15 sec) that covers several cardiac cycles [24] (Figure 2).
The EEO test can be used in patients who are not fully
paralyzed and deeply sedated, unless a too marked triggering
activity interrupts the 15-second EEO. Another limitation
of the EEO test is that it is much easier to assess with
a real-time measurement of cardiac output, such as pulse
contour analysis [24]. Even if the increase in arterial pulse
pressure during EEO is also indicative of fluid responsiveness
[24], it requires either printing the arterial pressure curve or
displaying the arterial pressure curve with a large scale, what
is not allowed by many standard bedside monitors.
The EEO test remains valid whatever the level of positive
end-expiratory pressure. One study reported that the pre-
diction of fluid responsiveness by the EEO test was reliable
and similar if the positive end-expiratory pressure was either
5 cmH
2
O or 13 cmH
2
O [25].
2.4. Fluid Challenge. The most intuitive way to test fluid
responsiveness is to administer a small volume of fluid,
observe its effects on cardiac output, and expect that a
subsequent larger volume expansion will exert similar effects
(Figure 1). The question is what should be considered as a
“small” volume of fluid. The disadvantage of the “common”
fluid challenge is that it consists of infusing 300–500mL
of fluid [26]. This volume is far to be negligible. Indeed,
performing the fluid challenge several times a day, as it can
be necessary at the early phase of shock, inevitably leads to
a significant total volume of fluid that contributes to fluid
overload.
A “mini fluid challenge” has been described as an alterna-
tive [27]. In an interesting study, the effects of only 100mL of
colloid on stroke volume predicted the response of cardiac
output to a 500mL volume expansion. These changes in
stroke volume were estimated by echocardiography [27].
Nevertheless, small amounts of fluid can only induce small
changes in stroke volume and cardiac output. Thus, this
test requires a very precise technique for measuring cardiac
output.Whether echocardiography is precise enough in non-
experts’ hands is far to be certain.The interest of more precise
measurements of cardiac output will likely be investigated.
2.5. The Passive Leg Raising (PLR) Test
2.5.1. Hemodynamic Effects. In a patient lying in the semire-
cumbent position, elevating the inferior limbs at 45∘ and
lowering the trunk induces a transfer of venous blood from
the lower part of the body toward the cardiac cavities. PLR
increases right and left cardiac preload and acts like a tran-
sient and reversible “self-volume challenge” [28] (Figure 1).
The reliability of PLR as a test of preload responsiveness has
been demonstrated by several studies. An increase of cardiac
output above approximately 10% predicts the response to
a subsequent volume expansion with good sensitivity and
specificity [29]. A recent meta-analysis of all studies per-
formed with the PLR test confirms its strong reliability [30].
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Figure 2: Decision-making algorithm of fluid administration. ∗Very initial phase of septic shock, when no fluid has been administered yet:
in case of haemorrhagic shock or in case of hypovolemic shock due to diarrhoea, vomiting, or ketoacidosis, for instance.
2.5.2. Advantages, Limitations, and Technical Considerations.
Since its hemodynamic effects occur over a long period of
time, PLR remains valid in case of cardiac arrhythmias and
spontaneous breathing activity. The hemodynamic effects of
PLR are independent from mechanical ventilation, which
explains that the PLR test can be used in some conditions
in which PPV is not valid, such as low tidal volume, low
lung compliance, and very high respiratory rate (Figure 2).
The postural change used for PLR is important to consider.
Firstly, the test should start from the semirecumbent and
not from the horizontal supine position [33]. Indeed, if it
starts from the semirecumbent position, PLR includes the
lowering of the trunk, which is associated with a transfer
of venous blood from the large splanchnic compartment to
the cardiac chambers. It was actually demonstrated that this
technique exerts larger hemodynamic effects compared to a
horizontal starting position [34]. Secondly, it is important to
move the bed of the patient and not the patient itself, because
sympathetic stimulations induced by passive hip movement
and painmay invalidate themeasurement [33]. In this regard,
the absence of an increase in heart rate during the PLR test
should be checked as it shows that the changes in cardiac
output are not related to sympathetic stimulation.
Another important point regards themethod thatmust be
used for assessing the PLR-induced hemodynamic changes
[33]. Firstly, these effects cannot be assessed by observing
the simple arterial pressure. Indeed, it has been demonstrated
that the PLR-induced changes in arterial pulse pressure
unreliably predict preload responsiveness, with a significant
number of false negatives [29]. This is most likely due to
the fact that PLR modifies the physiological properties of
the arterial tree, thus changing the relationship between
arterial pulse pressure and stroke volume. Thus, a technique
that directly measures cardiac output is mandatory [33].
Secondly, the effects of PLRmust be assessedwith a technique
providing a real-time measurement of cardiac output. The
maximal effect on cardiac output usually occurs within one
minute [29]. In some patients with a strong vasodilatation
and capillary leak, the effects of PLR progressively van-
ish over a few minutes. This explains why pulmonary or
transpulmonary thermodilution techniques, which take tens
of seconds to repeat cold fluid boluses, are not suitable. The
PLR method has been tested by esophageal Doppler and the
changes in aortic blood flow, with pulse-contour analysis and
the changes in cardiac output, cardiac output measured by
bioreactance and endotracheal bioimpedance cardiography,
subaortic blood velocity measured by echocardiography and
ascending aortic velocity measured by suprasternal Doppler
[33]. Interestingly, in patients on mechanical ventilation
with perfectly regular ventilation, the PLR-induced changes
in cardiac output could be simply and noninvasively be
estimated by the changes in end-tidal carbon dioxide [35, 36].
This should allow using the PLR test in the absence of any
cardiac output monitoring device.
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Intra-abdominal hypertension could reduce the validity
of the PLR test. It has been suggested that intra-abdominal
hypertension could create an obstacle to the transfer of blood
from the lower limbs toward the cardiac chambers through
the inferior vena cava [37]. One study suggested that the
PLR test was not reliable anymore if the intra-abdominal
pressure was higher than 16mmHg [38]. Nevertheless, this
study did not measure the intra-abdominal pressure during
PLR. Thus, this possible limitation of the PLR test needs
further confirmation.
2.6. Using Predictors of Fluid Responsiveness in Practice.
The prediction of fluid responsiveness should be considered
differently upon the clinical setting. First, one must remem-
ber that preload dependence is a physiological condition.
Thus, positive predictors of fluid responsiveness should lead
to volume expansion only in case of circulatory failure.
Second, in case of an obvious hypovolemia, detecting preload
dependence is useless since fluid responsiveness is constant.
This is the case at the very initial phase of septic shock,
when no fluid has been already administered, in case of
hemorrhagic shock or in case of hypovolemic shock due to
diarrhea, vomiting, or ketoacidosis, for instance.
The operating theatre might be particularly adapted for
the respiratory variation of stroke volume or surrogates in
anesthetized patients, except if low tidal volumes are used
for mechanical ventilation. In addition, such indices can
be assessed by means of a simple arterial catheter or by
noninvasive hemodynamic monitoring devices, which are
suitable for this setting. The EEO test might also be useful,
provided that the ventilator allows interrupting ventilation at
end-expiration for 15 sec.
In critically ill patients, the frequent presence of cardiac
arrhythmias, the low lung compliance and ventilation with
low tidal volumes associated with ARDS, and the presence
of some spontaneous breathing and of low lung compliance
often prevent use of PPV and the related indices. The
respiratory variation of vena cava can be used as an alternative
in case of cardiac arrhythmias. The EEO and PLR tests are
often suitable provided that their conditions of application are
fulfilled.
The utility of predictors of fluid responsiveness may also
depend upon the context where they are used. In the peri-
operative setting, prediction of fluid responsiveness might be
part of the preemptive, individualized hemodynamic treat-
ment that has been shown to reduce the rate of postoperative
complications and the hospital length-of-stay in different
categories of surgical patients [39–41]. In the context of
intensive care, indicators of preload dependence may be par-
ticularly useful to differentiate between fluid responder and
nonresponder patients, hence avoiding “underresuscitation”
and/or “overresuscitation,” both of which are associated with
poor prognosis in case of septic shock and ARDS [42].
3. The Risks of Fluid Therapy
Today, we possess clear evidence of how detrimental unjus-
tified and unbalanced fluid administration might be. Similar
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Figure 3: The risks of insufficient and excessive fluid resuscitation.
GIPS—global increased permeability syndrome.
to several therapeutic interventions, fluid administration is
obviously a life-saving intervention in severe hypovolemia
and dehydration; however, it can also exert a number of
adverse and potentially life-threatening effects (Figure 3).The
effects of infusion therapy are determined by discovery of
the novel mechanisms in fluid exchange. Thus, a recognition
of two new important players, glycocalyx barrier and active
water transporters (aquaporins), led to the critique of the
Starling concept [43, 44]. The pathophysiological findings of
the shift from intravascular to subglycocalyx oncotic pressure
resulted in substantial change of our knowledge of the process
of vascular fluid transport [45, 46]. Currently, wemust realize
that fluid distribution within the body of critically ill patients
has become as unpredictable as ever.However, understanding
these mechanisms during fluid therapy can be helpful to
prevent its potential risks and follow the primum nil nocere
principle.
3.1. “ThirdHit” of Shock. Anumber of guidelines recommend
an aggressive and early “rescue” fluid resuscitation, partic-
ularly in severe sepsis, hemorrhagic shock, and necrotizing
pancreatitis [47–49]. The body of evidence has shown that
fast repletion of fluid deficit in shock using crystalloid and/or
colloid solutions within a period of first 3–24 hours after
admission prevents the critical decrease of oxygen delivery,
attenuates the severity of multiple organ dysfunctions, and
reduces the incidence of adverse effects. However, everything
has its price. The most common type of dysoxia in ICU,
distributive shock, can be associated with delayed “flow”
phase global increased permeability syndrome (GIPS) [50].
Under conditions of increased vascular permeability, mainly
due to glycocalyx injury and disturbances of lymphatic flow,
fluids are leaving vascular bed and expand the interstitium.
This scenario results in total weight gain and edema for-
mation, influencing the volumes and interstitial pressure in
lungs, splanchnic viscera, and peripheral tissues. An increase
of body weight by more than 10% compared with baseline
during ICU stay confirms the hyperhydration and may result
in secondary and, hence, delayed organ dysfunction—which
may be referred to as “third hit” of shock [51, 52].
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The primary aim of the fluid load is to increase car-
diac output and oxygen delivery in patients with com-
promised oxygen transport. Thus, the dynamic parameters
and functional hemodynamic tests can be of great value
in determining the clinically effective volume of fluid load.
However, in distributive shock associated with severe GIPS
targeting “normal” preload and cardiac index can result in
life-threatening complications. In severe ARDS, burns, or
shock associatedwith necrotizing pancreatitis even restrictive
fluid load can be accompanied by intense fluid accumulation
in the tissues, particularly in the lungs, leading to increase
in extravascular lung water (EVLW), hypoxemia, and pul-
monary edema. This dilemma exerts a “therapeutic conflict”
that forces us to modify the goal-directed intervention and
consider “permissive hypovolemia” [53].Without any doubts,
this approach can be especially useful in the settings of
advanced volumetric and metabolic monitoring.
3.2. Fluid Resuscitation or Accumulation. In the literature,
we can find wide range of terms describing fluid therapy
in both ICU and perioperative settings including “liberal,”
“conservative,” and “restrictive.” In the review of Bundgaard-
Nielsen et al. [54]merging results of sevenmajor randomized
studies, the volume of intraoperative “liberal” approach
ranged from 2750 to 5388mL, while “restrictive” approach
was limited to 998–2740mL. Therefore, the exact borders of
these strategies are rather blurred, requiring individualized
goal-directed titration of the fluid in most cases.
In the ICU, an excessive fluid load in the settings of GIPS,
systemic inflammatory response syndrome, and multiple
organ dysfunction, particularly, in ARDS and acute kidney
injury (AKI), can be devastating (Table 1). The RENAL study
has shown that negative net fluid balance is an independent
predictor of reduced 90-day mortality and increased post-
ICU lifespan [55]. In this study, the handling of negative fluid
balance significantly decreased the duration of renal replace-
ment therapy and length of ICU stay. Therefore, the goal of
“negative fluid balance” should be widely adopted as impor-
tant part of the delayed goal-directed therapy of critically ill
patients.The spontaneous (Deescalation) or triggered (“Evac-
uation”) removal of excessive fluid becomes the link of the
modern “chain of ICU survival”—“Rescue-Optimisation-
Stabilisation-Deescalation/Evacuation” (ROSD/E, see Sec-
tion 4.2) [51, 52]. One from the examples for such an
approach represents goal-directed ultrafiltration resulting in
attenuation of intraabdominal hypertension (guided by intra-
abdominal pressure (IAP)), volume overload (guided by
global end-diastolic index), and pulmonary edema (guided
by EVLW) [56].
During the perioperative period, the liberal fluid therapy
is commonly justified by presumption of perioperative dehy-
dration and losses into hypothetical “third space.” Current
evidence shows that in many patients these factors can
hardly be assumed as an important reason for perioperative
hemodynamic distress and should not be considered as a
prerequisite for the aggressive intraoperative or preoperative
fluid load [57]. Thus, in neuraxial anesthesia, vasodilatation
caused by arterial hypotension is often treated with extensive
fluid load; however, under these conditions the increase in
preload does not counteract vasodilation and rarely increases
systemic arterial pressure [58, 59]. Furthermore, several stud-
ies demonstrated that postoperative weight gain is associated
with the risk of severe complications [60]. Along with other
perioperative factors (ischemia-reperfusion, cytokine release,
hyperoxia, etc.) excessive fluid load may be accompanied
by release of atrial natriuretic peptide and the injury of the
glycocalyx layer [61]. Moreover, in major abdominal surgery,
liberal fluid therapy can pose the risk of increased IAP, respi-
ratory complications, and delayed anastomosis leakage [62].
Therefore, the risks of fluid resuscitation can mainly be
related to the following factors:
(1) volume and rate of fluid administration (deliberate or
excessive fluid load),
(2) reperfusion phenomenon and microcirculatory rec-
ruitment,
(3) fluid-specific complications (AKI for hydroxyethyl
starches (HES) or dilutional acidosis for unbalanced
crystalloids).
3.3. Choice of Fluid. The choice of type of fluid does probably
not primarily affect the clinically important outcomes related
to the adverse effects of hyperhydration. However, at later
stages the effects of type of fluid become unequivocal.
According to the range of the current guidelines the use
of albumin and semisynthetic colloids does not carry any
obvious benefits over crystalloids and can be harmful in
particular subgroups of patients like traumatic brain injury
[63]. The risks of acute kidney injury and coagulation
disorders related to HES-administration are well recognized
in numerous studies [64]. On the other side, some guidelines,
for example, European Society of Anesthesiology, comment
that, compared with crystalloids, hemodynamic stabilization
using isooncotic colloids (albumin, HES)may decrease tissue
edema (the quality of evidence, “C”) [48]. Indeed, if colloids
are leaking from the vascular bed under settings of GIPS and
glycocalyx flaking, they can hold the fluid within the intersti-
tium at similar extent like within the intact vasculature.
Initial fluid resuscitation should routinely be started with
crystalloid solutions. However, according to Marik [60],
hyperhydration with unbalanced crystalloids can result in
“Iatrogenic salt water drowning.” Beyond the particular prob-
lem of hyperhydration, high dose of crystalloids, particularly
0,9% NaCl, increases the net chloride load, resulting in
hyperchloremia and hyperchloremic (dilutional) metabolic
acidosis. These disturbances were claimed to increase the
risk of AKI and mortality [65, 66]. Thus, implementing the
protocols of early goal-directed therapy, the use of high
doses of unbalanced crystalloids should be avoided. The
rational approach might be based on the administration
of balanced, “chloride-restricted” crystalloids or, probably,
in some situations (like refractory shock and ARDS in the
absence of AKI and coagulopathy), on the combination of
crystalloidswith limited (up to 15mL/kg) volumes of colloids.
3.4. Chapter Underline. It is important to note that the goal-
directed fluid therapy aiming to central venous pressure, as
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Table 1: The risks of excessive fluid load.
Settings Adverse effect Comment
Perioperative
Hyperchloremia and dilutional acidosis Can be reduced using anion-balanced crystalloid solutions
Reduced rate of wound healing Can be related to the peripheral tissue edema
Increased risk of anastomosis leakage Intestinal edema and decreased splanchnic perfusion
Increased IAP Intestinal and abdominal wall edema
Increased risk of respiratory complications Pulmonary and chest wall edema. Stressfully increased work ofbreathing
ICU
GIPS and glycocalyx injury The decrease of subglycocalyx oncotic pressure facilitates the capillaryleakage
Increased IAP/ACS and polycompartment
syndrome
Can be associated with polycompartment syndrome resulting in AKI,
liver dysfunction, FRC reduction, and ileus
Deranged oxygenation, pulmonary and
chest wall edema, incidence, or increased
ARDS severity
EVLWI increase. The fluid load is an independent risk factor of ARDS
Enteropathy Gut edema, bacterial translocation, malabsorption, and livercongestion
Brain edema and increased ICP Albumin is risky
Kidney injury Edema of kidney parenchyma with increase of 𝑃INT and decreasedGFR
Myocardial injury Dilatation, ANP release, and myocardium edema associated withdiastolic dysfunction (relaxation) and blockade
Increased mortality
IAP: intraabdominal pressure, ICP: intracranial pressure, ACS: abdominal compartment syndrome, GIPS: global increased permeability syndrome, ANP: atrial
natriuretic peptide, ARDS: acute respiratory distress syndrome, EVLWI: extravascular lung water index, and GFR: glomerular filtration rate.
Table 2: The risks of increased central venous pressure.
Consequence Comment
Decreased venous return and cardiac
index
CVP is not a reliable characteristic of preload and, when exceeding 8mmHg,
can be an independent predictor of the mortality [31]. The normal CVP value
is close to 0. According to Guyton model, both venous return and cardiac
output are determined by difference between 𝑃MS and CVP. An increase in
CVP can result in decrease of CO when it is not associated with concomitant
𝑃MS augmentation
Acute kidney injury
Increased CVP is associated with increased renal (subcapsular) (interstitial)
pressure resulting in decreased renal blood flow, GFR, and derangement in
lymph drainage. CVP is a sole hemodynamic parameter that can
independently predict the risk of AKI starting from the values above 4mmHg!
In CVP above 15mmHg, the risk of sepsis-induced AKI exceeds 80%
Splanchnic congestion/and
microcirculatory changes [32]
The microcirculation should be recognized as a low pressure part of
circulation due to abrupt decrease in blood pressure on the level of resistive
arterioles. Therefore, the critical changes in microcirculation have been
demonstrated in CVP > 12mmHg. Any increase in downstream pressure
(CVP) results in microcirculation distress
𝑃MS: mean (systemic) filling pressure, CVP: central venous pressure, and CO: cardiac output.
still required by Surviving Sepsis Campaign [47], in many
situations can be dangerous due to number of reasons and
should be avoided [31, 32, 60]. The detrimental effects of
forced CVP increase can result in numerous complications
presented in Table 2. Both insufficient and excessive fluid
resuscitation can be detrimental for the organ function
and result in deterioration of clinical outcome both in
ICU patients and in major surgery. This important clinical
dilemma can be resolved using up-to-date advancedmethods
of hemodynamic and metabolic monitoring and “phasic”
approach to fluid management of critically ill patients.
4. Timing and Use of Protocols for
Fluid Therapy
4.1. Protocols for Fluid Management. In previous chapters,
we have demonstrated several measures to differentiate
between patients who would or would not benefit from
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Table 3: Four phases of hemodynamic treatment.
Rescue Optimization Stabilization Deescalation
Treatment goal Shock reversal/Lifesalvage Adequate tissue perfusion
Zero-to-negative
daily fluid balance
Fluid accumulation
reversal/edema
resolution
Time course Minutes Hours Days Up to weeks
Hemodynamic
targets
Autoregulatory
thresholds of
perfusion pressure
Micro/macrocirculatory
blood flow parameters
Weaning of
vasopressors with
stable hemodynamic
conditions
Return to
premorbid/chronic
values of pressure and
flow
Treatment
options
Rapid fluid boluses +
vasopressors
Repeated fluid challenges +
vasopressors + Inotropes
Maintenance fluids +
decreasing/chronic
vasoactive agents
Diuretics or other
means of fluid
removal
fluid administration or in fact require fluid removal. Con-
sequences of inadequate or overzealous fluid administration
were also discussed. From this point of view, it sounds
rational to use strategies enabling individual titration of fluid
balance which should be associated with better outcomes in
critically ill patients. However, it seems that our praxis is
very divergent [5, 67–69]. This may be due to controversies
existing in the evidence supporting currently available fluid
and/or hemodynamicmanagement protocols.The two recent
large multicenter trials ARISE [70] and PROCESS [71] in
septic patients showed that protocol-led care (namely, early
goal-directed therapy according to Rivers et al. [72]) was
comparable to standard “do-what-you-want” treatment in
severe sepsis and/or septic shock. The outcomes observed in
patients managed using advanced hemodynamic monitoring
(with no protocol) were comparable to those without also in
other studies [73, 74]. In a recent Chinese study treatment
according to transpulmonary thermodilution derived volu-
metric variables based protocol also showed no measurable
benefit [75] although this study received serious criticisms as
well [76, 77].
Even in the perioperative setting where numbers of single
and multicenter trials have proved significant benefit of
advanced hemodynamic monitoring guided management on
morbidity, contradictory results have also been published
recently.The largest study so far on this topic, the OPTIMISE
trial [78], failed to prove its primary outcome of the compos-
ite 30-daymoderate to major morbidity andmortality. In this
last part of this paper we would try to shed some light on
this disproportion and offer the reader a rational approach
to the use of individualized protocols and hemodynamic
monitoring tools.
4.2. Timing of Fluid Interventions (the ROSD/E Concept).
It has been established in various scenarios that timing is
crucial: immediate commencement of resuscitation and of
the time within the target end-points reached is of utmost
importance in critical care medicine. As recently pointed out
by some most renowned authors [79, 80] four phases are
distinguishable in the time course of critical illness: Rescue,
Optimization, Stabilization, and Deescalation/Evacuation. In
each of these four stages’ treatment modalities, goals and
monitoring tools will substantially differ (Figure 4, Table 3).
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Figure 4: Four phases of hemodynamic treatment in relation to
cumulative fluid balance.
4.2.1. Rescue. The Rescue phase encompasses the very first
minutes to hours aiming at salvage of the patient. Naturally,
only those readily available tools and minimalistic targets
may be considered. In some cases, overtreatment may even
be associated with harm as, for instance, overresuscitation
to higher perfusion pressure with fluids in multiple trauma
victims [81]. Evidence is lacking to support the use of
protocols in this period. The EGDT/SSC protocol [47],
namely, its first part (20mL/kg bolus and further fluid and
vasopressor administration to reach the MAP of 65mmHg),
may be considered as an example of resuscitation for patients
with septic shock. However, there are some controversies
regarding the predefined amount of fluid bolus, which varies
from 20mL/kg [71] to 40mL/kg [82], but a single bolus of
1000mLs has also been used [70]. One can also argue that
considering the patients’ individual premorbid conditions,
higher or lower values of MAP may be more beneficial
then what is recommended as a universal target in the
guidelines. Reaching the lower autoregulatory threshold of
the most vulnerable organs (heart and brain) seems to be the
cornerstone.This is reflected in the usually proposed pressure
targets: SAP of 80mmHg (MAP 55mmHg) in overall young
and healthy population of trauma victims and MAP of
65mmHg in septic patients mostly older with comorbidities.
Besides standard pressure measurements, ultrasonography
and echocardiography may offer valuable advanced informa-
tion on heart function, including preload, contractility, and
ventricular performance.
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4.2.2. Optimization. In the Optimization phase, the ther-
apeutic goal should be to reach the optimal perfusion of
peripheral tissue and, according to some authors, to repay
the oxygen debt incurred through the previous course of
acute illness [83]. It is necessary to emphasize that this phase
seems to be time limited. Kern and Shoemaker [84] in their
meta-analysis indicated that optimization of tissue perfusion
should be done in the time-window of 24 hours after the
insult, although physiological rationale suggests limiting
oxygen debt for the shortest time possible. Studies trying
to reach predefined oxygen delivery targets later failed to
improve outcome [85, 86].This time limitmay prompt the use
of protocols to assure appropriate care. Fluids, vasopressor,
inotropes, and vasodilators are the most commonly used
measures to reach optimization goals. Fluids are themainstay,
but in the case of decreased vascular tone vasopressors
should be used as early as possible in order to minimize
the pathological pooling of blood and help mobilizing the
unstressed volume [87]. Providing inotropic support should
be reserved for those patients who after optimizing both pre-
and afterload still show unsatisfactory heart performance
coupled with signs of organ hypoperfusion.
Nevertheless, this pathophysiological rationale based
approach is not supported by robust clinical data among
critically ill patients, but several studies demonstrated benefit
(length of stay and morbidity) in trauma victims [88, 89]. In
severe sepsis, recent multicenter trials [70, 71, 75] proved that
protocols based on targets with low predictive value for fluid
responsiveness and local tissue perfusion (i.e., static parame-
ters, CVP or ITBV, and continuous ScvO
2
) are comparable to
consultant-led treatment alone. Similarly, there is no evidence
supporting the early use of advanced hemodynamicmonitor-
ing. With widespread use of critical care echocardiography
many information on the heart performancemay be gathered
with the use of a transthoracic probe and with standard
monitoring (i.e., arterial pressure curve). More invasive tools
of adequate reliability may help to manage difficult patients
and also help less experienced physicians to understand the
underlying physiology and follow treatment goals. In this
view of low evidence, only general recommendation may be
derived for the everyday care (Figure 5).
4.2.3. Optimization in the Perioperative Setting. Perioperative
goal-directed therapy (pGDT) has a special place in this
topic of the protocol-guided therapy in the Optimization
phase. In contrast to other critical care scenarios, both time
and severity of the insult are well defined. Furthermore,
the population of patients undergoing surgery is usually
more homogenous from many aspects. Numerous studies
and meta-analyses suggested that pGDT reduces the risk
of postoperative complications [41, 90]. Still some contro-
versy exists regarding the use of perioperative hemodynamic
optimization. First, the rising use of less invasive hemody-
namic monitoring devices led to widening of the indication.
Nowadays less severe patients and procedures are considered
suitable for pGDT as compared to previous years [40].
However, it follows simple logic that in these patients with
reduced risks for perioperative complications only limited
benefit may be expected. In fact the opposite may be true,
as in a fit patient with better cardiopulmonary reserves;
optimizing circulating volume tomaximize the stroke volume
may lead to unnecessary and potentially harmful positive
fluid balance and accumulation [91]. Also, targeting the
perioperative care to reach global preset values of oxygen
delivery lacks advantage of individually tailored care andmay
be detrimental in some patients [92].
Nevertheless, surgical patients undergoing general anes-
thesia with controlled mechanical ventilation are ideal can-
didates for using dynamic predictors of fluid responsiveness
(mostly based on heart-lung interactions) to rationalize intra-
operative fluid therapy. Using stroke/pulse pressure volume
variation or its surrogates was shown to be effective in
reaching better outcomes and reducing postoperative compli-
cations in a recently publishedmulticenter trial [93] as well as
in a large meta-analysis [39]. Despite these promising results,
dynamic variables have certain limitations. In a recent study
by Cannesson et al., it was found that fluid responsiveness
could not be predicted reliably and pressure variation was
in the range of 9–13%, also called the “grey zone,” which is
found in 24%of the cases undergoing surgery [94]. Regarding
inotropes, until proved otherwise the use of inotropes should
be limited for patients not achieving adequate stroke volume
despite satisfactory preload and there are signs of suboptimal
global tissue perfusion such as abnormal ScvO
2
, high lactate,
and increased central venous-arterial CO
2
-gap. Adequate
bedside tools and targets of regional tissue perfusion capable
of monitoring microcirculation are, however, still undeter-
mined.
4.2.4. Stabilization and Deescalation/Evacuation. There is
limited data regarding protocolized care in Stabilization
and Deescalation. Aggressive initial treatment followed by
a restrictive approach was demonstrated to be beneficial by
Murphy et al. [95]. In ARDS patients FACTT [96] and recent
FACTT lite trials [97] demonstrated that restrictive main-
tenance in stabilization phase was associated with improve-
ment in outcome. It is of vital importance to recognize the
right moment to stop the optimization, but unfortunately
we possess no evidence based data to elucidate this critical
moment. However, conventional indicators, such as the reso-
lution of oliguria, a decrease in lactate levels, and improving
ScvO
2
, can be helpful but may not occur in every patient.
However, it is important to acknowledge that none of these
indices have a high enough sensitivity on their own to be
used as a target in every patient; therefore, the so-called
“multimodal” approach,meaning to take all that into account,
may be necessary. At any case, if the optimization phase lasts
longer than 24 hours after the initial insult, it is not associated
with improved outcomes.
Similar to the rather blurred borderline between Opti-
mization and Stabilization phases the optimalmoment for the
initiation of Deescalation is also unresolved. Inmany patients
the fluid “Deescalation” is a naturally occurring process as a
result of the spontaneous healing, during which forcing fluid
removal is unnecessary. However, in some cases either the
positive fluid balance is too large or the ability of the patient
to mobilize the edema is diminished by the disease and
active intervention is necessary. For this reason, a “diuretic
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Figure 5: Decision algorithm for fluid loading in optimization phase.
responsiveness test” was recently introduced [98], whichmay
help to identify those patients being able to reach negative
fluid balance by receiving diuretics. Achieving negative fluid
balance by the combined administration of albumin and
furosemide was shown to improve outcomes in a small trial
[99] and in a retrospective study [100]. However, in some
patients the response for diuretics remains poor. In these
cases an active Deescalation by extracorporeal means, also
termed “Evacuation,” may be considered. Nevertheless, the
evidence is too weak to enable us to develop universally
applicable protocolized treatment in these patients [101].
4.3. Chapter Underline. Cardiovascular insufficiency due to
critical illness is a very heterogeneous entity. As pointed by
Vincent et al. [102], patient populations are often defined
as syndromes based on gross phenotypic variables (fever,
tachycardia) rather than on distinct features of disease origin
or chronic conditions. Mixing population of ARDS patients
with septic ones may have altered the results of Zhang
et al. study [75]. Severe sepsis due to pneumonia needs
totally different approach to septic shock of intraabdominal
origin in regard of fluid and hemodynamic treatment. These
circumstances were probably recognized by an experienced
clinician in the control arm of ARISE [70] or PROCESS [71]
trials but may be neglected by protocol treatment.
5. Conclusions
Several tools are available today to assess volume respon-
siveness using dynamic procedures. These tools enable us to
administer fluid with the assurance that it will lead to the
expected increase in cardiac output. In particular, this should
be included into the protocols guiding the hemodynamic
treatment in the operating room setting. In the intensive
care unit, these tools may be particularly useful in order to
refrain from volume expansion that should reduce the risk of
overzealous fluid administration. Further studies elucidating
the kinetics of glycocalyx injury/regeneration and the role of
vascular permeability during the goal-directed, individual-
ized approach to the fluid resuscitation are warranted. The
type and volume of the fluid should be thoroughly selected
considering the phase of shock, risk of impending organ
dysfunction, and individual comorbidity.
Failure to use the time-patient-tool-protocol adequate
approach may lead to worse outcomes and false conclusions.
Use of protocols without proper individualization will always
offer simplistic solution and can never lead to improvement
of care in all patients coming from some global population of
different disease states and severity. In other words, protocols
of care can never replace the well-educated and critically
thinking physician, who is able choose the appropriate
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diagnostic tools, put all relevant data into context, and tailor
treatment to the patients’ individualized needs.
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